Clinical Trialblazers invites you into the world of biotech leaders as they share the untold stories behind their journeys to bring breakthrough innovations to life. This 10 episode monthly series asks biotech visionaries to explore pivotal moments in their careers and the milestones that shaped their lives. Through unscripted conversations, host Alberto Grignolo dives into the decisions, risks, and accomplishments that define these trialblazers legacies to uncover the heart, grit, and ingenuity driving the future of scientific innovation.
All content for Clinical Trialblazers is the property of Parexel and is served directly from their servers
with no modification, redirects, or rehosting. The podcast is not affiliated with or endorsed by Podjoint in any way.
Clinical Trialblazers invites you into the world of biotech leaders as they share the untold stories behind their journeys to bring breakthrough innovations to life. This 10 episode monthly series asks biotech visionaries to explore pivotal moments in their careers and the milestones that shaped their lives. Through unscripted conversations, host Alberto Grignolo dives into the decisions, risks, and accomplishments that define these trialblazers legacies to uncover the heart, grit, and ingenuity driving the future of scientific innovation.
Bedside to Biotech: Dr. Sam Blackman on Building Trust, Storytelling in Science, and Pediatric Cancer Innovation
Clinical Trialblazers
52 minutes 50 seconds
3 weeks ago
Bedside to Biotech: Dr. Sam Blackman on Building Trust, Storytelling in Science, and Pediatric Cancer Innovation
In this episode of Clinical Trialblazers, host Alberto Grignolo sits down with Dr. Sam Blackman, co-founder and former Chief Medical Officer of Day One Biopharmaceuticals, board member of the Pediatric Brain Tumor Foundation, Bonum Therapeutics and CureSearch for Children's Cancer, and the new Entrepreneur in Residence at Google Ventures. Sam talks about his career journey from physician to biotech executive, and navigating the complexities of clinical trials, especially within pediatric oncology. He also discusses the critical need to connect the science, patients, and investment thesis together into a coherent story when fundraising in drug development.
2:37 - How he was pulled to pediatric medicine
6:00 - His decision to transition into drug development to impact exponentially more patients.
16:40 - The importance of connecting you vision to your company name
26:04 - How making those risky decisions in drug development can have profound impacts on patient outcomes
40:00 - The Power of Storytelling in Science and Business
47:57 - Advice for biotech entrepreneurs seeking capital
Clinical Trialblazers
Clinical Trialblazers invites you into the world of biotech leaders as they share the untold stories behind their journeys to bring breakthrough innovations to life. This 10 episode monthly series asks biotech visionaries to explore pivotal moments in their careers and the milestones that shaped their lives. Through unscripted conversations, host Alberto Grignolo dives into the decisions, risks, and accomplishments that define these trialblazers legacies to uncover the heart, grit, and ingenuity driving the future of scientific innovation.
